Unlock instant, AI-driven research and patent intelligence for your innovation.

Oxyalkanoyl clinfloxacin derivatives and their preparation methods and applications

A technology of oxyalkanoyl clinfloxacin and its derivatives, which is applied in the field of drug synthesis

Active Publication Date: 2022-05-31
SOUTHWEST UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The previous research experience shows that it is possible to continue to discover new highly active molecules with further changes to the structure of Clinfloxacin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oxyalkanoyl clinfloxacin derivatives and their preparation methods and applications
  • Oxyalkanoyl clinfloxacin derivatives and their preparation methods and applications
  • Oxyalkanoyl clinfloxacin derivatives and their preparation methods and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1, the preparation of intermediate N-chloroacetyl Clinfloxacin (IM1)

[0027]

[0028] Add 1 mmol of clinfloxacin hydrochloride and 2 mL of dichloromethane (DCM) into a 100 mL round bottom flask, cool in an ice bath, stir with a magnetic force, and add NaHCO 3 3.5mmol, after 20min, add 2mL of 2.5mmol of 2-chloroacetyl chloride DCM solution dropwise with a constant pressure dropping funnel. 2 O 15mL and DCM 20mL, adjust pH=2-3 with 2N HCl, separate the layers, extract the aqueous phase with DCM (15mL×2), combine the organic phases, wash with saturated NaCl solution (15mL), anhydrous NaCl 2 SO 4 Dry and rotary evaporate to obtain a crude product, separate and purify by column chromatography to obtain a viscous pure product, add ethyl acetate (EA) 5mL to dissolve, add petroleum ether (PE) 10mL while stirring, a large amount of white solid precipitates, suction filter, dry, 10.370 g of intermediate IM was obtained as a white solid with a yield of 83.6%. Th...

Embodiment 2

[0031] Embodiment 2, the preparation of intermediate N-chloropropionyl Clinfloxacin (IM2)

[0032]

[0033] Add 1mmol of CLX hydrochloride and 2mL of DCM to a 100mL round bottom flask, cool in an ice-salt bath, stir with a magnetic force, and add NaHCO 3 4mmol, after 20min, add 2.5mmol of 3-chloropropionyl chloride 2.5mmol in DCM solution 2mL dropwise with a constant pressure dropping funnel. 2N HCl to adjust pH=2-3, separate the layers, extract the aqueous phase with DCM (20mL×2), combine the organic phases, wash with 0.5N HCl (10mL×3), wash with saturated NaCl solution (20mL×2), wash with water ( 10mL×1), anhydrous Na 2 SO 4 Dry and rotary evaporate to get the crude product, add EA 5mL to dissolve, add PE 10mL under stirring, a large amount of white solid precipitates, suction filter, dry to obtain 0.4g of white solid intermediate IM2, the yield is 81%. The results of other synthesis experiments of IM2 are shown in Table 2.

[0034] Other synthetic experimental resul...

Embodiment 3

[0036] Embodiment 3, the preparation of intermediate N-chlorobutyryl Clinfloxacin (IM3)

[0037]

[0038] Add CLX hydrochloride 10mmol and DCM 25mL into a 100mL round bottom flask, stir at -5°C, add NaHCO after 15min 3 40mmol, after 10min, add dropwise the mixture of 2.8mL of 4-chlorobutyryl chloride and 6mL of DCM with a constant pressure dropping funnel. Stir, adjust pH to about 2 with 2N HCl, separate liquid, collect organic phase, wash with water, anhydrous Na 2 SO 4 Dry and rotary evaporate under reduced pressure to obtain a yellow oil, add EA 20mL, stir, add PE 50mL after 20min, a white solid precipitates, stand still, suction filter, dry, and obtain a yellow-white solid, namely intermediate IM3 4.132g, yield 88.08 %. The results of other synthesis experiments are shown in Table 3.

[0039] Other synthetic experimental results of compound IM3 of table 3

[0040]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a class of oxalkanoyl clinfloxacin derivatives with novel structure, which has the following structural formula, n is 1 or 2 or 3, and R is acetyl, propionyl, butyryl or H; All showed good activities, among which the activity of compound TM2 was comparable to that of the positive control drugs Clinifloxacin and moxifloxacin, and the activity of compound TM1 was even 2 times that of Clinifloxacin and nearly 2 times that of moxifloxacin. The sharing of IM1 has a synergistic effect; the study also found that the target of the compound TM1 is different from that of conventional fluoroquinolones; the results show that the highly active molecule has great potential for further development and can be used for the preparation of anti-inflammatory drugs. Tuberculosis drugs.

Description

technical field [0001] The invention belongs to the technical field of medicine synthesis, and relates to a new class of clinfloxacin derivatives, a preparation method thereof, and an application in pharmacy. Background technique [0002] Quinolones are a class of drugs with high efficiency, low toxicity, good selectivity and no cross-resistance to antibiotics. They have been used as first-line antibacterial drugs in clinic for a long time. Clinfloxacin (CLX) is an "extended-broad-spectrum" candidate molecule among the fourth-generation quinolone antibacterial drugs. It completed phase III clinical evaluation abroad in the 1990s, but due to phototoxicity and commercial reasons, it did not apply for marketing in the end. In the past 10 years, Yang Dacheng and others have carried out structural modification of Clinfloxacin, obtained various types of new Clinfloxacin molecules, and discovered many lead molecules with very good activity, improved stability, and reduced or almost...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/04A61P31/06A61K31/4725
CPCC07D401/04A61P31/06A61K31/4725A61K2300/00Y02A50/30
Inventor 杨大成谢建平谢文文许峻旗李洋岳琪佳李永清孙青羽范莉王浩霖任艳会
Owner SOUTHWEST UNIV